Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
440
datasets available to search
ShareScore release 0.9.0
Dataset results
440 results for “Dapagliflozin”
Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure
ClinicalTrials.gov study NCT03036124. IPD Sharing: Not stated. Countries: 20. Publications: 52.
Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes
ClinicalTrials.gov study NCT02518945. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The Effect of Dapagliflozin on Platelet Function testinG Profiles in Diabetic PatiEnts.
ClinicalTrials.gov study NCT04400760. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Dapagliflozin on Mitochondrial Dysfunction and Impaired Insulin Signaling/Action
ClinicalTrials.gov study NCT01439854. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dapagliflozin in Respiratory Failure in Patients With COVID-19
ClinicalTrials.gov study NCT04350593. IPD Sharing: NO. Countries: 7. Publications: 4.
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
ClinicalTrials.gov study NCT02653482. IPD Sharing: NO. Countries: 1. Publications: 5.
Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea
ClinicalTrials.gov study NCT02471404. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Dapagliflozin Effect in Cognitive Impairment in Stroke Trial
ClinicalTrials.gov study NCT05565976. IPD Sharing: YES. Countries: 1. Publications: 22.
Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT01646320. IPD Sharing: Not stated. Countries: 8. Publications: 3.
A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2
ClinicalTrials.gov study NCT02551874. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment
ClinicalTrials.gov study NCT00663260. IPD Sharing: Not stated. Countries: 13. Publications: 3.
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) Aged 10 to Below 18 Years Old
ClinicalTrials.gov study NCT03199053. IPD Sharing: YES. Countries: 23. Publications: 1.
A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in
ClinicalTrials.gov study NCT02419612. IPD Sharing: YES. Countries: 10. Publications: 1.
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
ClinicalTrials.gov study NCT01498185. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
ClinicalTrials.gov study NCT03030235. IPD Sharing: NO. Countries: 1. Publications: 6.
Effectiveness of Dapagliflozin for Weight Loss
ClinicalTrials.gov study NCT03968224. IPD Sharing: NO. Countries: 1. Publications: 89.
Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients
ClinicalTrials.gov study NCT00660907. IPD Sharing: Not stated. Countries: 10. Publications: 2.
Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack.
ClinicalTrials.gov study NCT04564742. IPD Sharing: YES. Countries: 2. Publications: 2.
Efficacy and Safety of Dapagliflozin in Acute Heart Failure
ClinicalTrials.gov study NCT04298229. IPD Sharing: NO. Countries: 1. Publications: 26.
Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial)
ClinicalTrials.gov study NCT04724837. IPD Sharing: YES. Countries: 19. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.